Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?

An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"

10 December 2012 (Monday), 2pm
NIH Conference Room (map)
University of the Philippines - Manila

Webpage shortcut: goo.gl/xszDH

Online Registration. Please register asap, as seats are limited. Confirmation will be needed.

Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA

Organizers

• PGC ELSI Program
• UP Manila Research Ethics Board
• UP Manila National Institutes of Health

Program

• Welcome Remarks - Dr Vicente Y. Belizario (Executive Director, UP Manila National Institutes of Health)
• Opening Remarks - Dr Carmencita David Padilla (Executive Director, Philippine Genome Center)
• "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?" - Dr Reidar K. Lie (Adjunct Research Fellow, US NIH)
• "Reviewing Genetic and Genomic Research: Issues and Challenges" - Dr Leslie Michelle M. Dalmacio (UP Manila Research Ethics Board)
• Reactor 1: Dr Filipinas Natividad (VP for Research and Biotechnology Division, St Luke's Medical Ctr)
• Reaction 2
• Open Discussion
• Closing Remarks

Inquiries

Please direct them to
psy@kssp.upd.edu.ph

See Also

“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center